Conditions: Seasonal Influenza Cough Sore Throat Nasal Congestion Myalgia Headache Fatigue
Keywords: influenza hospitalized flu antiviral
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 234
Healthy volunteers: no

Brief summary:
This is a Phase 3, open-label, randomized study of the antiviral activity, safety, and tolerability of intravenous Peramivir in hospitalized subjects with confirmed or suspected influenza infection.

Detailed description:

Arms:
arm 1: Peramivir 300 mg twice daily arm 2: Peramivir 600 mg once daily

Interventions: intervention 1: Peramivir intervention 2: Peramivir
Intervention descriptions: intervention 1: 300 mg twice daily intervention 2: 600 mg once daily

Protocol document: